Yahoo Web Search

Sign In

Search results

  1. seekingalpha.com › article › 4712738-heronHeron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call ...

    Aug 9, 2024 · Heron Therapeutics, Inc., (NASDAQ:HRTX) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ETCorporate ParticipantsCraig Collard - Chief Executive...

  2. marketwirenews.com › news-releases › heronHRTX - Heron Therapeutics Inc. (HRTX) Q2 2024 Earnings Call...

    Aug 9, 2024 · 2024-08-09 10:14:02 ET. Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Conference Call. August 6, 2024 16:30 ET. Corporate Participants. Craig Collard - Chief Executive Officer. Ira Duarte - Executive Vice President and Chief Financial Officer. Kevin Warner - SVP of Medical Affairs Strategy and Engagement. Conference Call Participants.

  3. herontherapeutics.gcs-web.com › news-releases › newsHeron Therapeutics Receives Complete Response Letter for HTX ...

    Jun 26, 2020 · Conference Call and Webcast. Heron will host a conference call and webcast today, June 29, 2020, at 9:00 a.m. ET (6:00 a.m. PT). The conference call can be accessed by dialing 877-311-5906 for domestic callers and 281-241-6150 for international callers. Please provide the operator with the passcode 3252267 to join the conference call.

  4. ir.herontx.com › news-releases › news-releaseHeron Therapeutics Announces Second Quarter 2023 Financial ...

    Jun 30, 2023 · Conference Call and Webcast . Heron will host a conference call and webcast on August 14, 2023 at 4:30 p.m. ET. The conference call can be accessed by dialing (646) 307-1963 for domestic callers and (800) 715-9871 for international callers. Please provide the operator with the passcode 5410567 to join the conference call.

  5. www.herontx.comAcute Care and Oncology Care Solutions | Heron Therapeutics

    Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients. At Heron, our mission is to improve the lives of patients by developing best-in-class medicines ...

  6. stockanalysis.com › stocks › hrtxHeron Therapeutics, Inc. (HRTX) - Stock Analysis

    Oct 25, 2024 · Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates. Net Product Sales of $34.7 million, which increased from $29.6 million for the same period in 2023. Net Loss Per Share $ (0.02), which decreased from $ (0.27) for the same period in 2023. 6 months ago - PRNewsWire.

  7. People also ask

  8. www.morningstar.com › news › pr-newswireHeron Therapeutics Announces Second Quarter 2024 Financial ...

    Aug 6, 2024 · Conference Call and Webcast Heron will host a conference call and webcast on August 6, 2024 at 4:30 p.m. ET. The conference call can be accessed by dialing (646) 307-1963 for domestic callers and ...